Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ACRSACRS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ACLARIS THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 609,158 shares of ACRS (ACLARIS THERAPEUTICS INC), worth $3.2M as of 2026-Q2. The position was increased (+3.5% shares). ACRS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$3.2M

Current Shares

609,158

Total Value Change

+$2.2M

Total Shares Change

+180,571

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
609,158
+3.5%
$3.2M0.0%$5.29
27
2026-Q1
Decreased
588,691
-6.9%
$2.2M0.0%$3.04
0
2025-Q4
Decreased
632,502
-33.8%
$1.9M0.0%$2.90
0
2025-Q3
Increased
956,051
+510.6%
$1.8M0.0%$1.92
42
2025-Q2
Decreased
156,572
-71.8%
$222,3330.0%$1.47
0
2025-Q1
Increased
555,953
+29.7%
$850,6080.0%$1.59
31
2024-Q4
New
428,587
-
$1.1M0.0%$2.48
35

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used